Peer Review History
| Original SubmissionJanuary 11, 2020 |
|---|
|
PONE-D-20-00937 Cessation of breastfeeding in mothers of preterm infants – a mixed method study PLOS ONE Dear Dr Ericson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please consider the detailed comments of the two peer reviewers, including the attachment provided by one of the reviewers, that support a recommendation of a major revision. The reviewer comments will also help to ensure a revised manuscript fully and clearly is in line with PLoS editorial recommendations that qualitative manuscripts include: 1) defined objectives or research questions; 2) description of the sampling strategy, including rationale for the recruitment method, participant inclusion/exclusion criteria and the number of participants recruited; 3) detailed reporting of the data collection procedures; 4) data analysis procedures described in sufficient detail to enable replication; 5) a discussion of potential sources of bias; and 6) a discussion of limitations. PLoS editorial suggests that authors use the COREQ checklist, or other relevant checklists listed by the Equator Network, such as the SRQR, to ensure complete reporting (http://journals.plos.org/plosone/s/submission-guidelines#loc-qualitative-research) to help facilitate this. We would appreciate receiving your revised manuscript by Apr 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Joann M. McDermid, MSc, PhD, RDN, FAND Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide.
[Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The inclusion criteria for both mothers and preterm infants are not explicitly stated. Measures to ensure validity and reliability of the data collection instrument used in the quantitative study was not indicated.The measures to ensure trustworthiness of the qualitative aspect of the study were also not made explicit in the manuscript. Some of the percentages do not sum up to 100%. Some of the words used and sentences need to be revised for clarity. Reviewer #2: Review of: Cessation of breastfeeding in preterm infants – a mixed method study. Introduction: The decline in breastfeeding of preterm infants are based on data from 2004-2013 from the Swedish National Quality Register. Are there not any newer data that can be drawn from the Register to evaluate current breastfeeding status? You refer to a study of breastfeeding problems as experienced by mothers of healthy infants with a GA of > 35 weeks. Several studies report preterm infants to be in increased risk of breastfeeding problems, and one might argue that breastfeeding problems of mature and premature infants might differ, for instance in prevalence, e.g. sleepy infant, not enough milk (which you also discuss later in your manuscript under discussion) Therefore you should also refer to studies of breastfeeding problems as experienced by mothers of preterm infants. Line 72-73: To have the possibility of breastfeeding as long as one wants, breastfeeding support is crucial. Yes!, but please support this by a reference. Method: The methods section needs to be revised. You should consider sub-headings in ‘Materials and methods’ to enhance the reading of the manuscript, e.g. sub-heading: Design, setting and participants, and sub-heading: Data collection, and sub-heading: Measures. Please state how many mothers were eligible for study in the study period and how many were approached about the study? You could also add a figure illustration the inclusion process and response rates during the study period. Did you have any ethical considerations in regard to recruiting participants; e.g. critical ill infant, mother with mental disease or psychological issues? When were mothers approached at the neonatal unit? At discharge? A week before? Please define exclusively and partial breastfeeding, e.g. did you follow WHO’s definition? And how was the mothers informed, as it seems as they self-reported breastfeeding status after discharge? Therefore, please state clearly when breastfeeding status were reported by healthcare professionals (at discharge?) and self-reported by mothers (after discharge?). Please elaborate on setting, e.g. were any hospitals ‘babyfriendly’ (BFIH)?, and inclusion criteria, e.g. were only singleton infants recruited? In Table 1 multiple births appears but should be mentioned in ‘Methods’. No exclusion criteria are mentioned? Please elaborate if you did or did not have any considerations in this regard, e.g. language? Line 104-106 and line 111-113 are unclear. Did you include data (free text) from the question mentioned in line 111-113 in your qualitative analysis if it described breastfeeding cessation? Line 139-140: How did you sort these comments as you described that they were sorted by breastfeeding as long as the mother wanted or not? Coding 6, 12 months after birth is according to the infants real birth date and not adjusted to gestational age (GA)? Please state shortly in line 96 if questionnaires were distributed according to real birth date. Argumentation for choice of method for qualitative analysis could be improved. Please state if you used any software to analyze the qualitative data. Please add a table illustrating your analysis and coding process, as it will enhance the reader’s ability to assess the quality of your analysis. Results: Response rates during the study period are missing, see comment under methods. Can you add a comment in regard to how the amount of qualitative data (total comments) were distributed in regard to who breastfeed as long as they wanted and who did not breastfeed as long as they wanted (line 131 -132) as you in your analysis state that comments were lacking in some themes from mothers not breastfeeding as long as they wanted (line 189-190). Line 178: drying up? Reflect upon wording as your quotes reflects mothers’ wording and the text your academic language, e.g. consider ‘insufficient milk supply’? Line 190: left or lack? Discussion: Line 305 and line 307: You say studies but only refer to one study? E.g. in breastfeeding problems there are many studies relevant to add as references. Line 342-343. Did you collect data in regard to solid food introduction in your study population? Or are there studies describing that solid food are introduced in preterm infants by 8-12 months after birth? That number is not adjusted to GA? As introduction of solid foods are earlier, as reported in term infants. Line 345-348. Please make your argumentation clear in short writing. , e.g. remove redundant text. Line 348: Are there any studies you could refer to as to support your hypothesis? Please elaborate further on strengths and limitations of your study as it by now is hardly described; e.g. what steps did you take to enhance the validity of your study? As your study is secondary analysis of data derived from a larger intervention study (RCT), you have not stated how it might have or have not affected the results of your study, which is an important issue to address, when reporting the validity of your findings. You should also add a short description about how you dealt with/used/reflected on your preunderstanding throughout your study (under Methods) as your preunderstanding can create bias and reduce validity. You could as well state if your e.g. profession could create potential bias. General reflections: The manuscript should be grammar checked as there are several typos and edited in the use of English, as some wordings could be improved. Several places in the manuscript authors’ names of references could be deleted as seems redundant text and will improve the reading of manuscript, e.g. for example, Feenstra et al and for example Gianni et al. Replace with only the reference in Vancouver style. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Cessation of breastfeeding in mothers of preterm infants – a mixed method study PONE-D-20-00937R1 Dear Dr. Ericson, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Joann M. McDermid, MSc, PhD, RDN, FAND Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-00937R1 Cessation of breastfeeding in mothers of preterm infants – a mixed method study Dear Dr. Ericson: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Joann M. McDermid Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .